Lack of compliance (non-adherence) to dosing regimens is becoming an international epidemic largely due to complicated regimen (e.g. too many medications, too frequent dosing) and swallowing difficulties. Eurand's Diffucaps technology enables the development of once-daily CR capsules or patient-compliant ODT CR comprising IR, SR, TPR or TSR bead populations multicoated with a weakly basic drug, an organic acid, a solid-solution and further coated with one or more functional polymers.
展开▼
